Flash Mob Study With Regard to Travel Willingness Among Patients With Cancer

Cancer Clinical Trial

Official title:

Flashmobstudie Landelijke Meting Reisbereidheid Medisch Oncologische Zorg

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05940753
• Other study ID #: 15954
• Status: Completed
• Start date: March 13, 2023
• Est. completion date: May 1, 2023

Study information

• Verified date: July 2023
• Source: University Medical Center Groningen
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This is a cross-sectional study in the form of a flash mob study, in which an inventory will be made on 13 and 14 March 2023 of the willingness to travel of oncology patients in the participating hospitals. Patients who have an appointment with an internist-oncologist or oncology specialist nurse at the outpatient clinic or by telephone and patients who come to day treatment unit for medical oncology are asked to participate. Willingness to travel is examined by means of a survey, in which a minimal set of categorized patient data (e.g. age, gender, level of education) is collected as part of the survey.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 5000
• Est. completion date: May 1, 2023
• Est. primary completion date: May 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

• Medical oncology patients with an appointment in the out-patient clinic or day treatment unit on 13 or 14 march 2023

• Medical oncology patients with an (video) call appointment in the out-patient clinic on 13 or 14 march 2023

Exclusion criteria:

• Patients in the inpatients oncology unit

• Medical oncology patients with no appointment on 13 or 14 march 2023

Related Conditions & MeSH terms

• Cancer

Intervention

Other:
• Survey about travel willingness regarding cancer treatment and follow-up
No intervention. Willingness to travel is examined through a survey. The survey will be conducted digitally, but may also be done on paper. In the survey a minimal set of categorized patient data (e.g. age, gender, level of education) is collected as part of the survey. For patients who cannot independently complete the questionnaire (for example due to low literacy skills), a volunteer, medical student or researcher is allowed to help the patient.

Locations

Country	Name	City	State
Netherlands	University Medical Center Groningen	Groningen

Sponsors (1)

Lead Sponsor	Collaborator
University Medical Center Groningen

Country where clinical trial is conducted

Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Travel willingness	How far is the oncological patient willing to travel for his/her systemic treatment or follow-up?	1 day
Secondary	Facilitating and inhibiting factors for willingness to travel	What are facilitating and inhibiting factors in patients' willingness to travel?	1 day
Secondary	Which patient characteristics are associated with willingness to travel?	Which patient characteristics are associated with willingness to travel? (age, type of cancer, curative/palliative treatment, distance to nearest hospital)	1 day